IRIS
DEROSA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.877
AS - Asia 15.609
EU - Europa 13.107
SA - Sud America 1.895
AF - Africa 225
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 20
Totale 49.766
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.493
CN - Cina 9.716
SG - Singapore 3.158
IE - Irlanda 2.937
UA - Ucraina 2.521
DE - Germania 2.014
FI - Finlandia 1.681
BR - Brasile 1.572
HK - Hong Kong 1.463
RU - Federazione Russa 1.202
IT - Italia 976
SE - Svezia 803
VN - Vietnam 485
GB - Regno Unito 451
CA - Canada 253
IN - India 165
FR - Francia 145
AR - Argentina 113
BD - Bangladesh 94
MX - Messico 84
IQ - Iraq 80
NL - Olanda 79
ZA - Sudafrica 70
EC - Ecuador 65
JP - Giappone 60
TR - Turchia 53
ID - Indonesia 50
PL - Polonia 44
ES - Italia 40
IR - Iran 32
PE - Perù 32
EG - Egitto 31
MA - Marocco 31
BE - Belgio 30
PK - Pakistan 30
VE - Venezuela 28
UZ - Uzbekistan 27
RO - Romania 26
CO - Colombia 24
PY - Paraguay 24
JO - Giordania 20
LT - Lituania 20
CL - Cile 19
GR - Grecia 18
KE - Kenya 18
MU - Mauritius 17
TN - Tunisia 17
NZ - Nuova Zelanda 16
EU - Europa 15
IL - Israele 15
TH - Thailandia 15
AE - Emirati Arabi Uniti 14
AL - Albania 14
AT - Austria 14
CH - Svizzera 14
CZ - Repubblica Ceca 13
DZ - Algeria 13
SA - Arabia Saudita 13
AU - Australia 12
AZ - Azerbaigian 12
KZ - Kazakistan 12
PH - Filippine 12
UY - Uruguay 11
DO - Repubblica Dominicana 10
KG - Kirghizistan 9
MK - Macedonia 9
JM - Giamaica 8
PT - Portogallo 8
BH - Bahrain 7
MY - Malesia 7
NP - Nepal 7
AM - Armenia 6
KR - Corea 6
PA - Panama 6
RS - Serbia 6
SN - Senegal 6
TT - Trinidad e Tobago 6
BO - Bolivia 5
LV - Lettonia 5
MD - Moldavia 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
CR - Costa Rica 4
EE - Estonia 4
GE - Georgia 4
HN - Honduras 4
KW - Kuwait 4
LB - Libano 4
OM - Oman 4
QA - Qatar 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
NI - Nicaragua 3
Totale 49.714
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.395
Dublin 2.937
Chandler 2.846
Nanjing 2.513
Dallas 1.533
Hong Kong 1.458
Singapore 1.187
Ashburn 1.154
Boardman 1.097
Nanchang 1.092
Beijing 923
Princeton 807
Shenyang 767
Hebei 702
Lawrence 700
Changsha 683
Wilmington 655
Jiaxing 575
Munich 537
Medford 521
Hangzhou 433
Tianjin 426
Helsinki 414
Los Angeles 400
Redondo Beach 302
Buffalo 260
Moscow 201
Ho Chi Minh City 181
Milan 181
São Paulo 160
New York 143
Shanghai 142
Toronto 140
Ann Arbor 138
Seattle 119
Woodbridge 115
Norwalk 111
Hanoi 98
Fairfield 78
Jinan 77
Turku 77
Kunming 69
Des Moines 61
Guangzhou 60
Tokyo 55
Brooklyn 54
Cambridge 54
Johannesburg 53
Ningbo 52
Rio de Janeiro 52
Santa Clara 51
Pavia 50
San Francisco 49
Montreal 48
Zhengzhou 46
Verona 40
Baghdad 39
London 38
Chicago 36
Orem 36
Stockholm 35
Pune 34
Warsaw 33
Chennai 32
Belo Horizonte 31
Orange 30
Quito 29
Atlanta 28
Boston 28
Brussels 28
Frankfurt am Main 28
Rome 28
Dhaka 27
Phoenix 27
Campinas 25
Tashkent 25
Eindhoven 24
Charlotte 23
Falkenstein 23
Poplar 23
Curitiba 22
Guayaquil 21
The Dalles 21
Brasília 20
Haiphong 20
Salvador 20
Bruino 19
Houston 19
Lanzhou 19
Mexico City 19
Porto Alegre 19
Genova 18
Taizhou 18
Washington 18
Amman 17
Bologna 17
Denver 17
Lima 17
Ankara 16
Changchun 16
Totale 32.155
Salva come PNG Salva come JPEG
Nome #
Effetto del lactobacillus paracasei I1688 e del lactobacillus salivarius I1794 (psmix®) sui lipidi ematici nell’ipercolesterolemia lieve 350
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 271
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 256
Anemia in patients with Covid-19: pathogenesis and clinical significance 255
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 231
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 230
A randomized, placebo-controlled study about the effect of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters 184
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 166
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 141
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 138
A multicenter, randomised, single-blind study on the effects of exenatide or glimepiride on insulin resistance. 136
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 130
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 128
A comparison between sitagliptin or glibenclamide in addition to metformin+pioglitazone on glycemic control and beta-cell function: the triple oral therapy 123
A nutraceutical based approach to reduce cholesterolaemia in patients previously intolerant of more than a statin: a pilot study 117
Diagnostico y Tratamiento de los desordenes lipidicos. Mc Graw Hill Education 2014. 116
A systematic reviewandmeta-analysis of randomized controlled trials investigating the effects of supplementationwith Nigella sativa (black seed) on blood pressure 115
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome 115
A randomized, double blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function. 114
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 114
A comparison study of Lp(a) plasma levels distribution between normo and hypertensive subjects with high BMI 113
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 112
Comparison between diet, orlistat and fluvastatin in obese patients with mild hypertension and hypercholesterolemia 112
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 110
Abscisic Acid Treatment in Patients with Prediabetes. 110
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 109
Confronto tra dieta, orlistat e fluvastatina in soggetti obesi, con ipertensione arteriosa lieve e ipercolesterolemia 109
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 109
Diarrea in paziente diabetico 109
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus 107
Atorvastatin-amlodipine combination and fibrinolytic balance in hypertensive hypercholesterolemic insulin-resistent patients 107
Comparison between orlistat and sibutramine in obese patients with mild hypertension 106
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 106
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 105
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 105
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 105
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 105
Confronto tra pioglitazone e rosiglitazone sul metabolismo glucidico e lipidico nei soggetti diabetici di tipo 2 in terapia con metformina 105
Effect of valsartan or olmesartan addition to amlodipine/hydrochlorotiazide combination on 24 hour blood pressure reduction in essential hypertension 103
A randomized, double-blind clinical trial on the long term efficacy of psyllium husk vs. guar gum on the clinical features of metabolic syndrome 103
Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women 102
Effects of berberis aristata/silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients 102
A randomized, double blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetic patients already treated with pioglitazone and metformin: a three years study 102
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial 101
A curious case of hypoglycaemia 101
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study 101
Confronto tra candesartan e olmesartan sui parametri correlati alla sensibilità insulinica nei pazienti ipertesi con diabete mellito di tipo 2 101
Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients 100
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 100
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 100
Adipocytokines levels in obese and non-obese subjects, an observational study 100
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 100
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 100
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 99
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients 99
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 99
Comparison between exenatide and glimepiride on metabolic control and on insulin resistance in type 2 diabetic patients with metformin therapy 99
Actions of glimepiride plus metformin compared to rosiglitazone plus metformin on glucose metabolism, fibrinolytic, and coagulation measurements in Type 2 diabetic patients. 99
n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia 99
Comparison between orlistat and sibutramine in obese patients with type 2 diabetes mellitus 98
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 97
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 97
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 97
Matrix metalloproteinase-2 activity (MMP-2) in children and adolescents with type 1 diabetes mellitus: Follow-up study 96
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 96
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 96
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 96
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 95
Effetti di pioglitazone e rosiglitazone nei pazienti con diabete di tipo 2 e sindrome metabolica trattati con metformina 95
A Randomized, Double-Blind, Controlled, Parallel-Group Comparison of Perindopril and Candesartan in Hypertensive Patients with Type 2 Diabetes Mellitus 94
Comparison between fosinopril and eprosartan on lipid profile and Lp(a) in normotensive, type 2 diabetic subjects, with microalbuminuria 93
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria 92
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome 92
Comparison between glimepiride plus pioglitazone vs. glimepiride plus rosiglitazone on glucose metabolism and on lipid, lipoprotein and apolipoprotein fractions in type 2 diabetic patients 92
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 92
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 91
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 91
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 91
Berberis aristata/silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients 91
Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea. 91
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 91
Lipoprotein (a) Particles Characterization by Dynamic Light Scattering 91
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 90
n-3 PUFAs on metalloproteinases, inflammatory and insulin resistance parameters in dyslipidemic patients after euglycemic clamp and oral fat load. 90
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 89
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation 89
Effects of sibutramine plus L-carnitine compared to sibutramine on inflammatory parameters in type 2 diabetic patients 89
Effects of rosiglitazone alone and in association with simvastatin on lipid and lipoprotein parameters in patients with metabolic syndrome 89
Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis 89
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 89
Effects of a combination of Berberis aristata, Silybum marianum and monacolin on lipid profile in subjects at low cardiovascular risk; a double-blind, randomized, placebo-controlled trial 89
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 88
Il controllo del paziente dislipidemico 88
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 88
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride 87
Telmisartan ed irbesartan nei diabetii di tipo 2 trattati con rosiglitazone: effetti sull'insulino-resistenza, la leptine e il TNF-alfa 87
Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial 87
Effetti metabolici di telmisartan e irbesartan nei apzienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 86
Confronto tra l'effetto anti-proteinurico dell'associazione telmisartan/amlodipina rispetto a losartan/amlodipina nel paziente con diabete di tipo 2, iperteso e microalbuminurico 86
Ipertensione e diabete, le complessità nella gestione del paziente 86
Totale 11.225
Salva come PNG Salva come JPEG
Categoria #
all - tutte 219.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.047 0 0 0 0 0 619 19 789 133 729 628 130
2021/20222.603 28 7 124 17 11 13 30 162 135 45 480 1.551
2022/20238.600 942 532 47 615 1.009 917 7 537 3.523 96 259 116
2023/20242.641 259 500 95 195 353 653 65 256 28 84 61 92
2024/20258.112 76 807 270 280 146 262 689 756 1.743 123 781 2.179
2025/20269.389 1.383 1.355 2.313 2.041 1.850 447 0 0 0 0 0 0
Totale 50.357